What is the appropriate management for a 56-year-old chronic smoker presenting with low‑grade fever, thick yellow sputum, nasal congestion, and rhinorrhea?

Management of Acute Exacerbation of Chronic Bronchitis in a Chronic Smoker

This 56-year-old chronic smoker with low-grade fever, thick yellow purulent sputum, and upper respiratory symptoms most likely has an acute exacerbation of chronic bronchitis (AECB), and the most critical intervention is immediate smoking cessation counseling, followed by antibiotic therapy given the presence of purulent sputum. 1

Immediate Assessment and Diagnosis

This clinical presentation fits the definition of acute exacerbation of chronic bronchitis: a sudden deterioration with increased cough, increased sputum volume (thick yellow sputum indicates purulence), often preceded by upper respiratory symptoms (runny nose, congestion). 1 The low-grade fever (99.2°F) and purulent sputum are key features suggesting bacterial superinfection.

Critical caveat: Given the 30-year smoking history, you must consider bronchogenic carcinoma if this represents a change in chronic cough pattern. 1, 2 However, the acute presentation with URI symptoms and fever makes AECB more likely as the immediate diagnosis.

Primary Management Strategy

1. Smoking Cessation (Grade A Recommendation)

Smoking cessation is the single most effective intervention for chronic bronchitis and must be addressed immediately. 1 The evidence is compelling:

• 90% of patients with chronic cough will have resolution after smoking cessation 1
• Benefits occur within the first year and are sustained long-term 1
• Approximately half of patients see improvement within 1 month 1

The fact that this patient "smoked a cigarette" (presumably recently) indicates active smoking and represents a critical intervention point during this acute illness.

2. Antibiotic Therapy (Grade A Recommendation)

Antibiotics are recommended for this acute exacerbation because the patient has purulent sputum (thick yellow), which is one of the cardinal symptoms. 1 The evidence shows:

• Antibiotics shorten the course of illness in AECB 1
• Most effective in patients with purulent sputum 1
• Most beneficial when patients have more severe symptoms or baseline airflow obstruction 1

Appropriate antibiotic choices (based on typical pathogens - Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae): 1

• Amoxicillin (higher dose than for simple URI)
• Macrolide (azithromycin or clarithromycin) if penicillin allergy
• Consider combination therapy if more severe presentation

Duration: Typically 5-7 days for uncomplicated AECB

3. Bronchodilator Therapy

Short-acting β-agonists (albuterol) should be initiated to control bronchospasm and relieve dyspnea; this may also reduce cough. 1 (Grade A recommendation)

Ipratropium bromide should be offered to improve cough. 1 (Grade A recommendation)

If no prompt response to one agent, add the other. 1

4. Symptomatic Management

For the nasal congestion and rhinorrhea:

• Intranasal decongestants (short-term use only, <3-5 days to avoid rhinitis medicamentosa) 3
• Oral decongestants may be considered with caution (monitor for hypertension, urinary retention)
• Intranasal anticholinergics (ipratropium nasal spray) can effectively reduce rhinorrhea 3

Central cough suppressants (codeine or dextromethorphan) are recommended for short-term symptomatic relief of coughing. 1 (Grade B recommendation)

What NOT to Do

• No prophylactic antibiotics for stable chronic bronchitis (Grade I - not recommended) 1
• No chest physiotherapy or postural drainage - not proven beneficial in stable or acute exacerbation 1
• No long-term oral corticosteroids - no evidence of benefit for cough/sputum, significant risks 1

Follow-Up and Red Flags

Arrange follow-up at 6 weeks to:

1. Obtain chest radiograph - essential given smoking history and age >50 to exclude lung cancer 4, 2
2. Assess response to smoking cessation
3. Evaluate for persistent symptoms requiring further investigation

Consider bronchoscopy if:

• Cough character changes and persists 1, 2
• Hemoptysis develops 2
• Chest radiograph shows persistent abnormalities 2
• No response to appropriate therapy

The incidence of lung cancer in middle-aged cigarette smokers is very high, and any prolonged change in cough character warrants investigation for bronchogenic carcinoma. 1

Clinical Pitfalls to Avoid

1. Don't dismiss the smoking cessation conversation because the patient is acutely ill - this is actually an ideal "teachable moment"
2. Don't prescribe antibiotics without addressing smoking - you'll be treating recurrent exacerbations indefinitely
3. Don't assume this is "just a cold" - the thick yellow sputum indicates bacterial involvement warranting antibiotics
4. Don't forget cancer screening - arrange that 6-week follow-up with chest X-ray given the smoking history